To determine whether maternofetal transmission of hepatitis B virus (HBV) is a common route of infection leading to chronic infection in west Africa, plasma samples, obtained at delivery from 1368 pregnant Ghanaian women and paired umbilical cord blood or newborn whole blood samples, were tested for HBV surface antigen (HBsAg) and DNA. A 16 % prevalence of HBV chronic carriers, defined as detectable HBsAg and/or HBV DNA, was found, >80 % contained less than 1×104 IU ml−1 HBV DNA and 99 % were infected with genotype E strains. HBV maternofetal transmission was documented in 17 out of 204 (8.3 %) paired HBV carrier women–cord blood/newborn samples. The rate of transmission was 55 % and 3.3 % when maternal viral load was above or below 1×104 IU ml−1, respectively (P=0.0008). Maternofetal transmission of HBV genotype E was estimated to account for 8 % of the cases of chronic HBsAg carriers. Six women with low viral load at delivery (five <20 IU ml−1) and anti-HBe (hepatitis B e antigen) transmitted HBV. Surprisingly, while non-transmitted low viral load strains had 79 % mutations at position 1896 of HBV genome, transmitted strains were all wild-type despite anti-HBe presence (P=0.0041), suggesting the possible role of HBeAg as risk factor for HBV maternofetal transmission. The relative risk of maternofetal transmission was 2.4 when pregnant women carried high viral load and 11.5 when carrying wild-type strains at position 1896, irrespective of viral load. We conclude that viral load and pre-core wild-type at position 1896 are two independent risk factors for HBV genotype E maternofetal transmission, which remains a minor contributor to high prevalence of chronic infection.
AllainJ.-P.,
CandottiD.,
SoldanK.,
SarkodieF.,
PhelpsB.,
GiachettiC.,
ShyamalaV.,
YeboahF.,
AnokwaM.other authors2003; The risk of hepatitis B virus infection by transfusion in Kumasi, Ghana. Blood 101:2419–2425[CrossRef]
BurkR. D.,
HwangL. Y.,
HoG. Y.,
ShafritzD. A.,
BeasleyR. P.1994; Outcome of perinatal hepatitis B virus exposure is dependent on maternal virus load. J Infect Dis 170:1418–1423[CrossRef]
CacciolaI.,
CerenziaG.,
PollicinoT.,
SquadritoG.,
CastellanetaS.,
ZanettiA. R.,
Mieli-VerganiG.,
RaimondoG.2002; Genomic heterogeneity of hepatitis B virus (HBV) and outcome of perinatal HBV infection. J Hepatol 36:426–432[CrossRef]
CandottiD.,
Opare-SemO.,
RezvanH.,
SarkodieF.,
AllainJ.-P.2006b; Molecular and serological characterization of hepatitis B virus in deferred Ghanaian blood donors with and without elevated alanine aminotransferase. J Viral Hepat 13:715–724[CrossRef]
ChuC. J.,
HussainM.,
LokA. S. F.2002; Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C. Gastroenterology 122:1756–1762[CrossRef]
DowB. C.,
PeterkinM. A.,
GreenR. H. A.,
CameronS. O.2001; Hepatitis B virus transmission by blood donation negative for hepatitis B surface antigen, antibody to HBsAg, antibody to hepatitis B core antigen and HBV DNA. Vox Sang 81:140[CrossRef]
GreenfieldC.,
OsidianaV.,
KarayiannisP.,
GalpinS.,
MusokeR.,
JowettT. P.,
MatiP.,
TukeiP. M.,
ThomasH. C.1986; Perinatal transmission of hepatitis B virus in Kenya: its relation to the presence of serum HBV-DNA and anti-HBe in the mother. J Med Virol 19:135–142[CrossRef]
IpH. M. H.,
LelieP. N.,
WongV. C. W.,
KuhnsM. C.,
ReesinkH. W.1989; Prevention of hepatitis B virus carrier state in infants according to maternal serum levels of HBV DNA. Lancet 1:406–410
KaoJ. H.,
ChenP. J.,
LaiM. Y.,
ChenD. S.2002; Clinical and virological aspects of blood donors infected with hepatitis B virus genotypes B and C. J Clin Microbiol 40:22–25[CrossRef]
KewM. C.,
KassianidesC.,
BergerE. L.,
SongE.,
DusheikoG. M.1987; Prevalence of chronic hepatitis B virus infection in pregnant black women living in Soweto. J Med Virol 22:263–268[CrossRef]
KuhnsM. C.,
KleinmanS. H.,
McNamaraA. L.,
RawalB.,
GlynnS.,
BuschM. P.The REDS Study Group2004; Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy. Transfusion 44:1332–1339[CrossRef]
LinH.-H.,
LeeT.-Y.,
ChenD.-S.,
SungJ.-L.,
OhtoH.,
EtohT.,
KawanaT.,
MizunoM.1987; Transplacental leakage of HBeAg-positive maternal blood as the most likely route in causing intrauterine infection with hepatitis B virus. J Pediatr 111:877–881[CrossRef]
LoY. M. D.,
LauT. K.,
ChanL. Y. S.,
LeungT. N.,
ChangA. M. Z.2000; Quantitative analysis of the bidirectional fetomaternal transfer of nucleated cells and plasma DNA. Clin Chem 46:1301–1309
MartinsonF. E.,
WeigleK. A.,
RoyceR. A.,
WeberD. J.,
SuchindranC. M.,
LemonS. M.1998; Risk factors for horizontal transmission of hepatitis B virus in a rural district in Ghana. Am J Epidemiol 147:478–487[CrossRef]
MenendezC.,
Sanchez-TapiasJ. M.,
KahigwaE.,
MshindaH.,
CostaJ.,
VidalJ.,
AcostaC.,
Lopez-LabradorX.,
OlmedoE.other authors1999; Prevalence and mother-to-infant transmission of hepatitis viruses B, C, and E in Southern Tanzania. J Med Virol 58:215–220[CrossRef]
OhtoH.,
LinH. H.,
KawanaT.,
EtohT.,
TohyamaH.1987; Intrauterine transmission of hepatitis B virus is closely related to placental leakage. J Med Virol 21:1–6[CrossRef]
Owusu-OforiS.,
TempleJ.,
SarkodieF.,
AnokwaM.,
CandottiD.,
AllainJ.-P.2005; Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource-poor settings. Transfusion 45:133–140[CrossRef]
PetitT.,
DommerguesM.,
SociéG.,
DumezY.,
GluckmanE.,
BrisonO.1997; Detection of maternal cells in human fetal blood during the third trimester of pregnancy using allele-specific PCR amplification. Br J Haematol 98:767–771[CrossRef]
ShepardC. W.,
SimardE. P.,
FinelliL.,
FioreA. E.,
BellB. P.2006; Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 28:112–125[CrossRef]
VranckxR.,
AlisjahbanaA.,
MeheusA.1999; Hepatitis B virus vaccination and antenatal transmission of HBV markers to neonates. J Viral Hepat 6:135–139[CrossRef]
WangZ.,
ZhangJ.,
YangH.,
LiX.,
WenS.,
GuoY.,
SunJ.,
HouJ.2003; Quantitative analysis of HBV DNA level and HBeAg titer in hepatitis B surface antigen positive mothers and their babies: HBeAg passage through the placenta and the rate of decay in babies. J Med Virol 71:360–366[CrossRef]
XuD.-Z.,
YanY.-P.,
ChoiB. C. K.,
XuJ.-Q.,
MenK.,
ZhangJ.-X.,
LiuZ.-H.,
WangF.-S.2002; Risk factors and mechanism of transplacental transmission of hepatitis B virus: a case-control study. J Med Virol 67:20–26[CrossRef]
XuH.,
PengM.,
QingY.,
LingN.,
LanY.,
LiangZ.,
CaiD.,
LiY.,
RenH.2006; A quasi species of the pre-S/S gene and mutations of enhancer II/core promoter/pre-C in mothers and their children infected with hepatitis B virus via mother-to-infant transmission. J Infect Dis 193:88–97[CrossRef]
ZhangS.-L.,
HanX.-B.,
YueY.-F.1998; Relationship between HBV viremia level of pregnant women and intrauterine infection: nested PCR for detection of HBV DNA. World J Gastroenterol 4:61–63